Skip to main content
Fig. 2 | Alzheimer's Research & Therapy

Fig. 2

From: Comparison of CSF markers and semi-quantitative amyloid PET in Alzheimer’s disease diagnosis and in cognitive impairment prognosis using the ADNI-2 database

Fig. 2

Distribution of baseline standardised uptake value ratio (SUVr) values by baseline status (control subjects, significant memory complaint [SMC], mild cognitive impairment [MCI], Alzheimer’s disease [AD]) in the cross-sectional cohort and by last known status (normal, MCI, AD) in the longitudinal cohort. Boxes represent IQRs. Whiskers correspond to mean ± 1.5 SD. CTL Control, NL Normal, ns Not significant

Back to article page

Alzheimer's Research & Therapy

ISSN: 1758-9193